2011
DOI: 10.3892/ol.2011.236
|View full text |Cite
|
Sign up to set email alerts
|

TP53 genetic alterations in Arab breast cancer patients: Novel mutations, pattern and distribution

Abstract: Abstract. Breast cancer remains a worldwide public health concern. The incidence and mortality of breast cancer varies significantly in ethnically and geographically distinct populations. In the Kingdom of Saudi Arabia (KSA) breast cancer has shown an increase in incidence and is characterized by early onset and aggressiveness. The tumor suppressor TP53 gene is a crucial genetic factor that plays a significant role in breast carcinogenesis. Furthermore, studies have shown a correlation between certain p53 muta… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

1
15
1

Year Published

2013
2013
2022
2022

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 16 publications
(17 citation statements)
references
References 35 publications
1
15
1
Order By: Relevance
“…These genes include ATM, TP53, CHECK2, PTEN, STK11, PALB2, BRIP, and the RAD51 genes (Merdad et al, ). In fact, the frequency of TP53 mutations among Saudi patients is one of the highest in the world (Al‐Qasem et al, ; Chopra & Kelly, ). Further researches are needed to elucidate the spectrum of mutations in those genes to confirm their association with the increase risk of developing breast cancer in the population.…”
Section: Discussionmentioning
confidence: 99%
“…These genes include ATM, TP53, CHECK2, PTEN, STK11, PALB2, BRIP, and the RAD51 genes (Merdad et al, ). In fact, the frequency of TP53 mutations among Saudi patients is one of the highest in the world (Al‐Qasem et al, ; Chopra & Kelly, ). Further researches are needed to elucidate the spectrum of mutations in those genes to confirm their association with the increase risk of developing breast cancer in the population.…”
Section: Discussionmentioning
confidence: 99%
“…Also, an excess of G:C>A:T transitions (49%) at non-CpG sites was noted, suggesting exposure to particular environmental carcinogens such as N-nitroso compounds. 126 In addition, several single nucleotide polymorphisms in Arab patients seem to be specific to the indigenous populations and could be associated with increased risk of breast cancer. Examples include: the p.Pro72Pro in the TP53 gene and the c.309GG in the MDM2 gene in Saudi women, the c.-251A IL8 allele in Tunisian women, and the c.1298A>C DNA polymorphism in the MTHFR gene in patients of Syrian ancestry.…”
Section: Neoplasmsmentioning
confidence: 99%
“…The risk originates from heritable mutations in specific genes. 8,9 The type of cancer is dependent on the mutated gene. Hereditary breast and ovarian cancers originate from BRCA1 and/or BRCA2 gene mutations that significantly increase the likelihood of developing breast, ovarian, prostate and other types of cancer.…”
Section: Introductionmentioning
confidence: 99%
“…1,10 Patients with Li-Fraumeni syndrome, characterised by TP53 mutations, have a heightened risk of cancer before age 30, and are almost guaranteed to suffer from cancer by the age of 60. 8,[11][12][13] Carriers of cancer syndrome associated genes also have a higher risk of multiple malignancies and rare cancers, and are more likely to develop cancer at a younger age.…”
Section: Introductionmentioning
confidence: 99%